In fact, research shows that changing biologics is common. After two years, 1 in 4 people with psoriasis change from one biologic to another. Doing so can help improve your quality of life. Here ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

Sufficient data from a 12-week non-clinical toxicology study of VYN202 in dogs would be required in order to resume the trial in male clinical subjects, and the design of this toxicology study has ...

Psoriasis can occur near the eyes, causing redness, itching, dryness, and flaking skin. Once it’s correctly diagnosed, you can often manage it with topical treatments.

Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid ...

The dermatology market in the U.S. is at a pivotal moment of transformation, with spending poised to climb from $40.55 billion in 2023 to $70 billion by 2030. This unprecedented growth mirrors past ...

U.K. adults with psoriasis may be compromising their health and risking exacerbating their skin condition by seeking ...

Arcutis is financially strong, with over 30 months of cash runway. The atopic dermatitis market is large and shifting away ...

A psoriasis flare can be a challenging experience. You have to manage psoriasis throughout your life, and at times the condition may erupt and cause new skin lesions to appear on your skin along ...

JACK MAYE didn’t want to tell anybody. In his freshman year, when he took off his Bedford High School football helmet and flakes fell out, Maye’s teammates would tell him that he had some bad dandruff ...